SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-042704
Filing Date
2023-05-24
Accepted
2023-05-24 16:21:05
Documents
4
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f6k0523_universe.htm 6-K 28430
2 NOTICE AND PROXY STATEMENT OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS, DATED f6k0523ex99-1_universe.htm EX-99.1 207860
3 FORM OF PROXY CARD TO BE MAILED TO SHAREHOLDERS OF THE COMPANY FOR USE IN CONNEC f6k0523ex99-2_universe.htm EX-99.2 36189
4 GRAPHIC togier_logo.jpg GRAPHIC 18235
  Complete submission text file 0001213900-23-042704.txt   298832
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 23954404
SIC: 2834 Pharmaceutical Preparations